MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Search

Prestige Consumer Healthcare

Closed

SectorHealthcare

65.43 -3.01

Overview

Share price change

24h

Current

Min

65.43

Max

67.72

Key metrics

By Trading Economics

Income

-5.3M

42M

Sales

25M

274M

P/E

Sector Avg

16.119

89.037

Profit margin

15.399

Employees

600

EBITDA

7.2M

87M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+18.66% upside

Dividends

By Dow Jones

Next Earnings

5 lut 2026

Market Stats

By TradingEconomics

Market Cap

223M

3.2B

Previous open

68.44

Previous close

65.43

News Sentiment

By Acuity

19%

81%

40 / 360 Ranking in Healthcare

Prestige Consumer Healthcare Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 sty 2026, 21:55 UTC

Earnings

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 sty 2026, 23:52 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 sty 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 sty 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 sty 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 sty 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 sty 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 sty 2026, 22:37 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 sty 2026, 21:59 UTC

Acquisitions, Mergers, Takeovers

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 sty 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

22 sty 2026, 21:44 UTC

Earnings

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 sty 2026, 21:32 UTC

Acquisitions, Mergers, Takeovers

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 sty 2026, 21:31 UTC

Acquisitions, Mergers, Takeovers

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 sty 2026, 21:31 UTC

Acquisitions, Mergers, Takeovers

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 sty 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 sty 2026, 21:30 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 sty 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Capital One To Acquire Brex >COF

22 sty 2026, 21:13 UTC

Earnings

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 sty 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 sty 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 sty 2026, 21:10 UTC

Earnings

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 sty 2026, 21:06 UTC

Earnings

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Rev $15.58B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q EPS $3.26 >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Net Interest Margin 8.26% >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Net $2.13B >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Adj EPS $3.86 >COF

22 sty 2026, 21:05 UTC

Earnings

Capital One 4Q Net Charge-Offs $3.8B >COF

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q EPS $2.21 >ISRG

Peer Comparison

Price change

Prestige Consumer Healthcare Forecast

Price Target

By TipRanks

18.66% upside

12 Months Forecast

Average 79.5 USD  18.66%

High 88 USD

Low 71 USD

Based on 4 Wall Street analysts offering 12 month price targets forPrestige Consumer Healthcare - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Sentiment

By Acuity

40 / 360 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat